Voleon Capital Management LP Invests $282,000 in Aspen Aerogels, Inc. $ASPN

Key Points

• Voleon Capital Management purchased 44,060 shares of Aspen Aerogels, valued at approximately $282,000, during the first quarter, owning about 0.05% of the company by the end of that period.
• Other hedge funds also increased their stakes in Aspen Aerogels, with Allspring Global Investments boosting its position by 96.2%, and institutional investors collectively owning 97.64% of the company's stock.
• Analysts rated Aspen Aerogels with a consensus of "Moderate Buy," while the stock's price target has varied from $10.00 to $19.50, reflecting differing outlooks on the company's market performance.

Voleon Capital Management LP bought a new stake in shares of Aspen Aerogels, Inc. (NYSE:ASPN - Free Report) in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 44,060 shares of the construction company's stock, valued at approximately $282,000. Voleon Capital Management LP owned approximately 0.05% of Aspen Aerogels as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also bought and sold shares of the company. Banque Cantonale Vaudoise purchased a new stake in shares of Aspen Aerogels during the 1st quarter worth $45,000. Exchange Traded Concepts LLC lifted its stake in shares of Aspen Aerogels by 460.4% during the 1st quarter. Exchange Traded Concepts LLC now owns 7,436 shares of the construction company's stock worth $48,000 after purchasing an additional 6,109 shares during the last quarter. CWM LLC lifted its stake in shares of Aspen Aerogels by 2,137.9% during the 1st quarter. CWM LLC now owns 8,325 shares of the construction company's stock worth $53,000 after purchasing an additional 7,953 shares during the last quarter. Teacher Retirement System of Texas purchased a new stake in shares of Aspen Aerogels during the 1st quarter worth $65,000. Finally, FORA Capital LLC purchased a new stake in shares of Aspen Aerogels during the 1st quarter worth $79,000. 97.64% of the stock is owned by institutional investors.

Insider Buying and Selling

In related news, CAO Santhosh P. Daniel sold 4,410 shares of the company's stock in a transaction that occurred on Tuesday, August 12th. The stock was sold at an average price of $7.31, for a total value of $32,237.10. Following the sale, the chief accounting officer owned 19,879 shares in the company, valued at $145,315.49. This represents a 18.16% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 3.40% of the stock is currently owned by corporate insiders.

Aspen Aerogels Stock Performance

NYSE ASPN traded up $0.15 during trading hours on Monday, reaching $6.74. The stock had a trading volume of 776,253 shares, compared to its average volume of 1,985,134. The stock has a fifty day moving average of $7.12 and a 200 day moving average of $6.47. The stock has a market cap of $554.69 million, a P/E ratio of -1.77 and a beta of 2.65. Aspen Aerogels, Inc. has a 52-week low of $4.16 and a 52-week high of $30.24. The company has a debt-to-equity ratio of 0.34, a quick ratio of 3.31 and a current ratio of 3.98.

Aspen Aerogels (NYSE:ASPN - Get Free Report) last issued its earnings results on Thursday, August 7th. The construction company reported ($0.04) EPS for the quarter, beating analysts' consensus estimates of ($0.12) by $0.08. The firm had revenue of $78.02 million for the quarter, compared to analyst estimates of $72.53 million. Aspen Aerogels had a positive return on equity of 2.92% and a negative net margin of 78.53%.Aspen Aerogels's revenue for the quarter was down 33.8% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.21 earnings per share. Aspen Aerogels has set its FY 2025 guidance at -3.860--3.730 EPS. Sell-side analysts predict that Aspen Aerogels, Inc. will post 0.17 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of equities research analysts have commented on ASPN shares. Barclays cut Aspen Aerogels from an "equal weight" rating to an "underweight" rating and increased their price target for the company from $7.00 to $16.00 in a research note on Monday, August 11th. Canaccord Genuity Group lowered their price target on Aspen Aerogels from $11.00 to $10.00 and set a "buy" rating for the company in a report on Friday, August 8th. One investment analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, two have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, Aspen Aerogels presently has an average rating of "Moderate Buy" and a consensus price target of $19.50.

Aspen Aerogels Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.